UPB: upstreambio.com Short-Term Debt to Equity
Upstream Bio Inc (UPB) is creating potential for high pricing power through the development of the verekitumab antibody to combat severe asthma. The company's operations are proceeding against a stable external backdrop devoid of sanction risks. This price chart featuring the 0.00 indicator demonstrates current price action. However, the financial position remains uncertain, as business sustainability relies on test results and new investments.
Analytical breakdowns for Upstream Bio Inc
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
General company analysis:Upstream Bio Corp UPB
Amid geopolitical instability and the risks of disrupted pharmaceutical substance supply chains, Upstream Bio Inc (UPB) requires stringent liquidity control. The GURU.Markets algorithm correlates short-term loans with equity, enabling investors to assess the business's dependence on rapid refinancing and the risk of losing financial stability through the current short-term liabilities-to-equity ratio.
Competing companies
Short-Term Debt to Capital ARGX|Short-Term Debt to Capital BNTX (BioNTech Pharma)|Short-Term Debt to Equity Abivax Pharma|admabiologics.com - Ratio of Short-Term Indebtedness to Capital|PTGX: Short-Term Debt to Equity|IMVT - Short-Term Debt to Equity Ratio|KNSA: Short-Term Debt to Capital|Short-Term Debt to Capital Grifols Biemat|ADPT - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital celldex.com|AUPH (Aurinia Pharmaceuticals Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient BCRX (BioCryst Pharmaceuticals, Inc.)|Vera Pharma - Short-Term Debt to Equity|Dianthus Corp - Short-Term Debt to Equity Ratio|PHVS: Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|TRML: Short-Term Debt to Equity Ratio|PGEN (Precigen Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Pharming (PHAR)|Short-Term Debt to Capital Ratio Nektar Corp|Zenas Biopharma Inc - Short-Term Debt to Capital|Current Liabilities to Capital immunome.com IMNM|Short-Term Debt to Equity Ratio GOSS (Gossamer Bio)|KalVista Pharma - Short-Term Debt to Capital|Short-Term Debt to Equity Septerna Corp|PVLA: Current Liabilities to Equity|Savara Inc. - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient rigel.com|AnaptysBio (ANAB) - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio ATXS|enGene Bio (ENGN) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital rapt.com (RAPT)|JBIO: Short-Term Debt to Capital|Current Liabilities to Capital aclaristx.com ACRS|Kyverna Therapeutics, Inc. - Short-Term Debt to Capital|TLSA: Short-Term Debt to Capital|CABA (Cabaletta Bio, Inc) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Ventyx Biosciences, Inc|THTX - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital avalotx.com|Short-Term Debt to Capital Eledon Pharmaceuticals, Inc. (ELDN)|Short-Term Debt to Equity Agenus, Inc. (AGEN)|Short-Term Debt to Capital CLYM|zurabio.com - Short-Term Debt to Capital Coefficient|ATYR (aTyr Pharma, Inc.) - Short-Term Debt to Equity|Adagene (ADAG) - Current Liabilities to Capital|Short-Term Debt to Equity Ratio ikenaoncology.com IMA|Shattuck Labs (STTK) - Ratio of Short-Term Indebtedness to Capital|EQ: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient CNTB|Short-Term Debt to Equity Immunic, Inc. IMUX|Short-Term Debt to Capital Ratio atarabio.com (ATRA)|InflaRx - Short-Term Debt to Capital|XFOR - Short-Term Debt to Equity Ratio|Adicet - Short-Term Debt to Equity Ratio|CELU: Short-Term Debt to Capital|Short-Term Debt to Equity INmune Bio, Inc. (INMB)|barinthusbio.com (BRNS) - Current Liabilities to Equity|Short-Term Debt to Capital Kezar Life Sciences, Inc.|Short-Term Debt to Equity SABS|AKTX - Short-Term Debt to Equity|Current Liabilities to Equity enlivex.com (ENLV)|Short-Term Debt to Capital Q32 Bio|Ratio of Short-Term Indebtedness to Capital geovax.com GOVX|Edesa Biotech - Short-Term Debt to Capital|IBIO: Short-Term Debt to Capital|Short-Term Debt to Equity carismatx.com CARM|XTLB (XTL Bio) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BOLT|Short-Term Debt to Equity Ratio HCW Biologics Inc|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com AIM|Short-Term Debt to Equity Ratio Aditxt, Inc.|Ratio of Short-Term Indebtedness to Capital GRI Bio Corporation GRI|Short-Term Debt to Capital XRTX (XORTX Therapeutics Inc.)|HIND: Short-Term Debt to Capital Coefficient|REVB (Revelation Biosciences, Inc.) - Short-Term Debt to Equity|INDP (Indaptus Therapeutics Inc) - Short-Term Debt to Equity Ratio|Short-Term Debt to Equity SCNI|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Equity Ratio AFMD|Short-Term Debt to Capital ALLK (allakos.com)|HOOK - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio IGM Biosciences Inc. IGMS|ITOS (iTeos) - Short-Term Debt to Capital|Ocean Biomedical Corp (OCEA) - Current Liabilities to Capital|TCBP: Short-Term Debt to Equity Ratio|THRD (thirdharmonicbio.com) - Short-Term Debt to Capital